Publications
47
Citations
126
Est. group size
~42
Recurring co-author estimate
Active years
7
Publishing since 2020
Adam Khorasanchi's work is clinical oncology research focused on cancers of the digestive and genitourinary systems, including pancreatic, bladder, prostate, and kidney cancers, as well as broader cancer treatment topics like immunotherapy side effects and supportive care for patients undergoing cancer treatment. Much of this research involves clinical trials, case reports, and studies looking at how patient characteristics (like body weight, sex, or race) relate to treatment outcomes. This work would suit students interested in translational and clinical cancer research, particularly studies that connect laboratory findings (like blood-based biomarkers) to real-world patient outcomes.
Publication output was minimal before 2020 but has grown substantially since, rising from single-digit counts in 2020-2022 to a peak of 13 in 2025, indicating an increasingly active and productive recent research period.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Cell-free DNA predictive epigenetic signatures (PSig) for risk stratification of pancreatic ductal adenocarcinoma (PDA) patients on palliative therapy.
Journal of Clinical Oncology · 2026
- Clinical outcomes of muscle-invasive and metastatic, bladder, and urethral pure adenocarcinoma (BUAdenoCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT).
Journal of Clinical Oncology · 2026
- Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors
Journal of Cancer · 2026
- Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer
Cancers · 2025
- MUC5AC levels as predictors of adjuvant therapy outcomes in pancreatic ductal adenocarcinoma: A study of post-surgical gemcitabine-based regimens.
Journal of Clinical Oncology · 2025
- Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature
Frontiers in Medicine · 2024
- Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial
The Oncologist · 2023
- Managing Nutrition Impact Symptoms in Cancer Cachexia: A Case Series and Mini Review
Kompass Nutrition & Dietetics · 2023
- Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
Frontiers in Oncology · 2023
- To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations
Transplantation and Cellular Therapy · 2023
- Salvage lenvatinib/everolimus (LE) combination therapy after immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) for metastatic renal cell carcinoma (mRCC).
Journal of Clinical Oncology · 2023
- Managing Nutrition Impact Symptoms in Cancer Cachexia: A Case Series and Mini Review
Frontiers in Nutrition · 2022
- Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
Cancers · 2022
- Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma
Case Reports in Hematology · 2022
- Melatonin supplementation for preventing cancer-related fatigue in patients receiving radiotherapy for early-stage breast cancer: A double-blind placebo-controlled phase III trial.
Journal of Clinical Oncology · 2022
- Journal of Clinical Oncology×17
- Cancers×3
- Journal of the National Comprehensive Cancer Network×3
- Cancer Research×3
- The Oncologist×1
- Kai He
Medicine · The Ohio State University
- Lingbin Meng
Medicine · The Ohio State University
- Yuanquan Yang
Medicine · The Ohio State University
- Joseph Azar
Medicine · The Ohio State University
- Andrew J. Gunderson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile